Cade Jobsis, 4, scheduled to receive novel gene therapy next month
Following a month-long community fundraising effort last year to cover $1.15 million in hospital and regulatory fees, 4-year-old Cade Jobsis was selected for a phase 3 clinical tri…
Following a month-long community fundraising effort last year to cover $1.15 million in hospital and regulatory fees, 4-year-old Cade Jobsis was selected for a phase 3 clinical tri…